Discover the latest predictions for the machine learning in pharmaceutical industry market, with a projected CAGR of 37.9% and revenue of $26,151.8 million by 2031. This report outlines the industry's characteristics, growth drivers, and challenges, making it an excellent resource for new entrants. With the growing demand for personalized treatment and behavioral modification, as well as machine learning's potential to accelerate drug discovery and improve medical diagnosis, this market is primed for growth. However, regulatory and legal challenges may present obstacles, though the Covid-19 pandemic contributed to growth in demand for machine learning techniques. This report covers the market's segmentation, key players, and future outlook in detail.
Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?